SAIMSARA Journal

Machine Generated Science • ISSN 3054-3991

CLTI Prognosis and Chronic Limb-Threatening Ischemia Outcomes: Scoping Review with ☸️SAIMSARA.

Cardiac & Vascular Health icon

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

DOI: 10.62487/saimsara9e1c0fc3

Editorial note
• Last update: 2026-05-03 12:42:18
What is this paper about
CLTI prognosis is not decided by the artery alone: this evidence map shows that wound severity, nutrition, frailty, heart failure, dialysis, mobility loss, and biomarkers together define who survives, heals, or loses a limb. The full review explains which clinical scores and warning signals may help identify high-risk patients before revascularization decisions are made.
Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.


Abstract: The aim of this review is to synthesize contemporary evidence regarding the prognostic factors, clinical scoring systems, and long-term outcomes for patients diagnosed with CLTI (Chronic Limb-Threatening Ischemia). The review utilises 74 original studies with 392683 total participants (topic deduplicated ΣN). The mapped evidence indicates that prognosis in CLTI is shaped less by any single anatomical feature and more by the convergence of wound severity, nutritional state, and systemic frailty, with 5-year amputation-free survival ranging from 26.5%–35.4% in high-risk groups to 72.1%–89.5% in low-risk groups. The Wound, Ischemia, and foot Infection (WIfI) classification and nutritional indices such as the Geriatric Nutritional Risk Index, Prognostic Nutritional Index, and Controlling Nutritional Status score emerged as the most recurrent independent predictors across cohorts, while revascularization was associated with improved 1-year amputation-free survival (58.0% versus 45.7% in tissue-loss disease). Recurrent secondary signals included hemodialysis, heart failure with reduced ejection fraction (2-year amputation-free survival 35% versus 61% in preserved ejection fraction), ambulatory decline (1-year survival 86.8% versus 23.9%), calcification burden, depression, and emerging inflammatory, microRNA, and metabolomic biomarkers, suggesting that prognosis is best understood as a multidomain construct rather than a purely vascular one. Clinically, this supports embedding combined wound, nutritional, frailty, and cardiac assessment into routine pre-revascularization workup to identify patients who may benefit from intensified medical optimization or alternative care pathways. The evidence map is, however, dominated by retrospective single-region cohorts with heterogeneous endpoints, which tempers certainty about the relative weight of individual predictors. Future research should prioritize prospective multicenter validation of composite prognostic scores integrating WIfI stage, nutritional indices, frailty, and novel biomarkers, alongside interventional trials testing whether modifying nutrition, depression, or ambulatory decline translates into measurable gains in amputation-free survival.

Keywords: Amputation-free survival; Chronic limb-threatening ischemia; Endovascular treatment; WIfI clinical stage; Hemodialysis; Heart failure; Nutritional risk index; Major amputation; All-cause mortality; Revascularization

Review Stats

Get access to the full paper

Unlock the full evidence map

The full evidence review, including the Introduction, Methods, Results, Discussion, Conclusion, figures, and complete reference index, opens after purchase or sign-in. The Evidence Object JSON is a separate machine-readable evidence product: a concentrated synthesis of results, topic-level evidence, and discussion across original and non-original studies. It can be directly input into your LLM, agent, or RAG workflow.

Reference Index (69)